Literature DB >> 35815080

Scars of stroke care emerge as COVID-19 shifts to an endemic in many countries.

Diana Alecsandra Grad1,2, Razvan Mircea Chereches1,2, Stefan Strilciuc1,2,3, Dafin Muresanu1,3.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35815080      PMCID: PMC9262269          DOI: 10.25122/jml-2022-1005

Source DB:  PubMed          Journal:  J Med Life        ISSN: 1844-122X


× No keyword cloud information.
COVID-19 has provoked a significant shift in health services delivery worldwide by limiting access to patients suffering acute episodes in need of immediate care [1, 2] and with chronic diseases [3], disrupting essential preventive efforts (i.e., immunization [4] and screening programs [5]), increasing burnout levels among health professionals (residents or senior staff) [6-8] and concentrating primary care providers in COVID-19-related surveillance and control efforts [9]. Stroke hospitalization rates (for ischemic [10] and hemorrhagic [11] stroke and transient ischemic attack (TIA) [2]) have been affected by the ongoing pandemic. Emergency assistance [12, 13] is a mandatory component of the stroke care protocol needed to increase survival rates. However, with multiple media reports [14, 15] pointing toward the growing cases of COVID-19 hospital outbreaks [16] (that affected hospitalized patients, hospitalization rates, and attending health professionals [17, 18]), fear of getting infected in the hospital was one of the causes of low admission for stroke rates. Other factors impairing hospital care and neurorehabilitation regimens were pre-and within-pandemic changes for shift patterns and the length of stay influenced by COVID-19 medical needs and the preventive measures [19]. The number of patients diagnosed and treated for stroke decreased in the first and second years of the pandemic. There were 25.3%, respectively 26.7% fewer thrombectomies and thrombolysis performed and 40% fewer stroke-related admissions in February 2020 compared to February 2019 in China [20]. In Spain, weekly stroke admissions reported for public hospitals from the North-West region reported lower statistically significant numbers (ranging from 14.5% to 6.5%). At the same time, in referral centers from other autonomous communities, results showed only slight changes (Cantabria and Navarra, of 0.5% and 2.5%) [10]. In Germany, declines in stroke cases have been more accentuated (17.4% for acute ischemic stroke and over 22% for TIA) [21]. In Qatar, the cases decreased by almost half (n=630) in the first three months of the pandemic [22]. A global cross-sectional analysis involving 70 countries and 403 countries analyzed stroke cases from November 2019 until June 2020 reported that the highest decrease in stroke hospitalizations was observed in Africa (30.2%), followed by North (18.8%) and South America (17.8%) [23]. In Europe, the number of stroke diagnoses dropped by 10.9%. As for intravenous thrombolysis, pandemic changes ranged from 24.2% (South America) and 9.9% (Asia). In Romania's 2021 edition of the OECD Country Health Profile, stroke is ranked as the second cause of mortality (with 221 deaths per 100 000 inhabitants), while the COVID-19 pandemic ranks 11th (with 83.06 deaths per 100 000 inhabitants) [24, 25] (Figure 1 and Figure 2). The ranking for stroke has been maintained since 2017, when the first country report was issued, although stroke attributable deaths decreased from 18% to 16.3% [26]. As an essential tool for decision-makers and stakeholders involved in the health services provision and planning process, this publication synthesizes socio-economic, morbidity and mortality and on health system performance indicators (financing, effectiveness, accessibility, and resilience) [27].
Figure 1

Number of deaths per 100,000 inhabitants computed using the crude numbers reported in individual Country Health Profiles for 2020 and country population retrieved from Worldometer [25].

Figure 2

Number of deaths per 100,000 inhabitants computed using the crude numbers reported in individual Country Health Profiles for 2020 and country population retrieved from Worldometer [25].

Number of deaths per 100,000 inhabitants computed using the crude numbers reported in individual Country Health Profiles for 2020 and country population retrieved from Worldometer [25]. Number of deaths per 100,000 inhabitants computed using the crude numbers reported in individual Country Health Profiles for 2020 and country population retrieved from Worldometer [25]. The report highlights that stroke and COVID-19 have been the leading causes of mortality within EU-27, Norway, and Iceland [28]. In most countries, stroke was ranked as the second and third cause of death. As for deaths caused by COVID-19, it was among the top three causes of death in twenty countries. There is considerable heterogeneity between countries regarding the percentage of total mortality. For example, COVID-19 deaths ranged from 1.1% to 15.5%, and stroke-related deaths were between 4.8% and 19.3%. Additional evidence points out that aside from COVID-19 hospital-acquired infections (3.3% in Europe and 8.4% in South America) [23], cases of stroke (as well as other neurological manifestations) [29] have been reported following laboratory-confirmed SARS-CoV-2 infection [30]. The high number of stroke cases [31] and deaths are due to modifiable (dietary, alcohol consumption, low level or lack of physical activity, and smoking) and nonmodifiable (age and sex) risk factors [32]. Behavioral risk factors are a leading cause of preventable deaths [33, 26]. Dietary risks, smoking, alcohol consumption, and low levels of physical activity are in the top five main risk factors contributing to preventable mortality and have been responsible for over 40% of the total Disability-Adjusted Life Years (DALYs) [34]. Therefore disease prevention and health promotion should be prioritized in healthcare delivery [35]. In 2014, there were 14% fewer hospital admissions referred by GPs than admissions due to a visit to the emergency department [36]. Primary [37] and secondary stroke prevention [38] reduce the burden of stroke cases and relapses as such intervention may decrease behavioral and control vascular risk factors, focusing on lifestyle changes and medication adherence [39]. The risk factor burden can be further decreased through health education and health promotion activities [40]. A quick PubMed search reveals that although the body of literature on risk factors is expanding, articles focusing on stroke prevention, health promotion, and education in countries such as Romania are scarce. Additionally, only a few studies assess the overall level of health literacy [41-43]. The COVID-19 pandemic has unquestionably played a significant role in decreasing records of stroke admissions and thus increasing stroke-related excess mortality [44] and jeopardizing access to rehabilitation for less severe cases. As both stroke and COVID-19 are public health problems with an immense burden on the healthcare system, efforts are needed on the one hand to coordinate emergency responses on all fronts to avoid endemic care disruption, and on the other hand to improve primary prevention and reverse the pyramid of service delivery, reducing overall pressure on health systems, achieving better value for money.
  31 in total

1.  Assessing health literacy in rural settings: a pilot study in rural areas of Cluj County, Romania.

Authors:  Oana M Pop; Alexandra Brînzaniuc; Emanuela O Sirlincan; Catalin O Baba; Razvan M Chereches
Journal:  Glob Health Promot       Date:  2013-12-04

2.  Changes in Characteristics, Treatment and Outcome in Patients with Hemorrhagic Stroke During COVID-19.

Authors:  Yuqi Chen; Fan Xia; Yunke Li; Hao Li; Lu Ma; Xin Hu; Chao You
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-12-15       Impact factor: 2.136

3.  Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis.

Authors:  Shubham Misra; Kavitha Kolappa; Manya Prasad; Divya Radhakrishnan; Kiran T Thakur; Tom Solomon; Benedict Daniel Michael; Andrea Sylvia Winkler; Ettore Beghi; Alla Guekht; Carlos A Pardo; Greta Karen Wood; Sherry Hsiang-Yi Chou; Ericka L Fink; Erich Schmutzhard; Amir Kheradmand; Fan Kee Hoo; Amit Kumar; Animesh Das; Achal K Srivastava; Ayush Agarwal; Tarun Dua; Kameshwar Prasad
Journal:  Neurology       Date:  2021-10-11       Impact factor: 9.910

4.  Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions.

Authors:  Jing Zhao; Hang Li; David Kung; Marc Fisher; Ying Shen; Renyu Liu
Journal:  Stroke       Date:  2020-05-20       Impact factor: 7.914

Review 5.  The 2018 Astana Declaration on Primary Health Care, is it useful?

Authors:  Gijs Walraven
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

6.  Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany.

Authors:  Daniel Richter; Jens Eyding; Ralph Weber; Dirk Bartig; Armin Grau; Werner Hacke; Christos Krogias
Journal:  Stroke       Date:  2020-12-24       Impact factor: 7.914

7.  A call to optimize haemodialysis vascular access care in healthcare disrupted by COVID-19 pandemic.

Authors:  Carlo Basile; Carlo Lomonte; Christian Combe; Adrian Covic; Dimitrios Kirmizis; Vassilios Liakopoulos; Sandip Mitra
Journal:  J Nephrol       Date:  2021-03-08       Impact factor: 3.902

8.  Burnout syndrome in Romanian medical residents in time of the COVID-19 pandemic.

Authors:  Mihai C T Dimitriu; Anca Pantea-Stoian; Alexandru C Smaranda; Anca A Nica; Alexandru C Carap; Vlad D Constantin; Ana M Davitoiu; Catalin Cirstoveanu; Nicolae Bacalbasa; Ovidiu G Bratu; Florentina Jacota-Alexe; Cristinel D Badiu; Catalin G Smarandache; Bogdan Socea
Journal:  Med Hypotheses       Date:  2020-06-07       Impact factor: 1.538

9.  The impact of the COVID-19 pandemic on cardiology services.

Authors:  Omar Fersia; Sue Bryant; Rachael Nicholson; Karen McMeeken; Carolyn Brown; Brenda Donaldson; Aaron Jardine; Valerie Grierson; Vanessa Whalen; Alistair Mackay
Journal:  Open Heart       Date:  2020-08

10.  SARS-CoV-2 outbreaks in hospitals and long-term care facilities in Germany: a national observational study.

Authors:  Beneditta Suwono; Annika Steffen; Birgitta Schweickert; Viktoria Schönfeld; Michael Brandl; Mirco Sandfort; Niklas Willrich; Tim Eckmanns; Sebastian Haller
Journal:  Lancet Reg Health Eur       Date:  2022-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.